Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under Coeptis Therapeutics Holdings, Inc. in our court records and SEC 8-K records (as of 2026-10-18).
- Leadership changes: the latest reported is Jeffery Harris, Chief Technology Officer (Form 8-K filed 2026-06-30). Check you are dealing with the people now in charge.
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Vanguard Capital Management (filed 2026-05-04).
Who is behind it
Z Squared Inc.: incorporated in Delaware; business address in Fort Lauderdale, Florida; industry Finance Services (Form 8-K, 2026-09-14).
Officers and directors, each with the role and the filing that names them:
- David Mehalick: Executive Officer, Director (Form D, 2025-08-07)
- Daniel Yerace: Director (Form D, 2025-08-07)
- Brian Cogley: Executive Officer (Form D, 2025-08-07)
- Christopher Calise: Director (Form D, 2025-08-07)
- Christopher Cochran: Director (Form D, 2025-08-07)
- Tara Maria DeSilva: Director (Form D, 2025-08-07)
- Philippe Deschamps: Director (Form D, 2025-08-07)
- Gene Salkind: Director (Form D, 2025-08-07)
| Report | Holder | Share |
|---|---|---|
| Schedule 13G/A, 2026-07-31 | Vanguard Capital Management | 3.41% |
| Schedule 13D/A, 2026-05-15 | Bsg Series Cm, LLC | 0% |
| Schedule 13G, 2026-05-04 | Vanguard Capital Management | 5.57% |
| Schedule 13D, 2026-05-04 | Bsg Series Cm, LLC | 80.73% |
| Schedule 13G, 2026-04-28 | Vanguard Capital Management | 5.57% |
| Schedule 13G/A, 2026-03-26 | The Vanguard Group | 0% |
| Schedule 13G, 2026-01-30 | The Vanguard Group | 6.35% |
| Filed | Person | Role | Change | Effective |
|---|---|---|---|---|
| Form 8-K, 2026-06-30 | Jeffery Harris | Chief Technology Officer | appointed | 2026-06-24 |
| Form 8-K, 2026-05-22 | Michelle Burke | Chief Executive Officer | departed | 2026-05-22 |
| Form 8-K, 2026-05-01 | Ryan Schadel | Chief Marketing Officer | appointed | |
| Form 8-K, 2026-05-01 | Ryan Schadel | appointed |
Money raised
| Filed | Sold | Offered |
|---|---|---|
| Form D, 2025-08-07 | $4M | $5M |
| Form D, 2024-06-27 | $4.30M | $10M |
| Form D, 2023-11-03 | $2M | $2M |
Latest IPO step: Z Squared Inc. filed to go public (S-1, 2026-06-26).
IPO filings: S-1, 2026-06-26, S-1, 2026-06-09, 424B4, 2025-04-23, S-1/A, 2025-04-04, S-1/A, 2025-02-07; ticker ZSQR on Nasdaq Global Market.
Acquisitions reported on Form 8-K, Item 2.01: completed an acquisition (2026-09-14); acquired Coeptis Therapeutics, Inc. (2026-04-30).
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
Permanent URL:
https://mentionfox.com/who-owns/z-squaredLast updated 2026-10-18
Primary record: Schedule 13G, 2026-05-04 · Form D, 2025-08-07 · Form 8-K, 2026-06-30 · Form 8-K, 2026-05-22
Who owns Z Squared Inc.? Owners, funding and legal record. MentionFox, 2026-10-18. https://mentionfox.com/who-owns/z-squared